Key facts
- It has raised $3.0M; the latest was Seed Round ($2.5M) in Apr 2026.
- Notable investors include EIT Food, Arise, Feast Ventures, Food Labs, Foodlabs (Hong Kong).
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Evanium Healthcare
- ·The full record, as it builds
Funding rounds
No funding rounds for Evanium Healthcare are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Evanium Healthcare
Developer of a drug delivery technology designed for improving the use of plant-based compounds. The company's technology advances the water solubility, dissolution rate, physical stability, bioavailability, taste, and processability of compounds, enabling pharmaceutical, food, cosmetic, and nutraceutical manufacturers to work effectively with poorly soluble compounds across oral and topical formulations.
- Sector
- Healthcare
- HQ
- Regensburg, Germany
- Founded
- 2019
- Employees
- 12
- Website
- evanium.de/
- Ownership
- Privately Held (backing)
Evanium Healthcare doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Evanium Healthcare shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Evanium Healthcare in its N-PORT filings yet. We sweep new filings monthly.